Compare BHST & JHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BHST | JHI |
|---|---|---|
| Founded | 2007 | N/A |
| Country | Canada | United States |
| Employees | 87 | N/A |
| Industry | | Trusts Except Educational Religious and Charitable |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.2M | 119.3M |
| IPO Year | N/A | 1994 |
| Metric | BHST | JHI |
|---|---|---|
| Price | $4.27 | $13.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 18.7K | ★ 19.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $116.40 | N/A |
| Revenue Next Year | $55.91 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.10 | $11.61 |
| 52 Week High | $12.80 | $14.51 |
| Indicator | BHST | JHI |
|---|---|---|
| Relative Strength Index (RSI) | 38.05 | 26.27 |
| Support Level | N/A | N/A |
| Resistance Level | $5.02 | $13.98 |
| Average True Range (ATR) | 0.23 | 0.12 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 13.39 | 0.00 |
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others. The company's portfolio includes Corporate Bonds, Term Loans, U.S Government Agency, and Others.